financetom
Business
financetom
/
Business
/
QuoteUnQuote with KK podcast will now incorporate vaccine and healthcare issues
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
QuoteUnQuote with KK podcast will now incorporate vaccine and healthcare issues
Dec 22, 2020 12:07 AM

QuoteUnQuote with KK, India's leading business podcast, is switching gears as it moves from business outlook to vaccine and health issues.

In its next season in 2021, the podcast will discuss the vaccine and health playbook and the future of the world in the new normal.

With over 175 million listeners globally, the business podcast, is a monthly talk show that invites top business professionals and thought leaders from across the worldwide to discuss business, economy, investments and socio-political issues. However, in 2021, it will run on two different tracks.

"We have been listening to our listeners, and next year season, we're going to run QuoteUnQuote with KK on two tracks - Healthy and Wealthy," Kapil Khandelwal, its producer and industry veteran, announced on December 17.

QuoteUnquote with KK addresses the Outside-In view of India for a global audience. Its last ten episodes have provided the listeners with an unbiased perspective on various issues from the pandemic, economic recovery, employment, capital markets, digital healthcare, geo-politics, and policy and reforms.

However, in line with audience feedback, the podcast will feature world leaders giving feedback on pandemic and recovery.

"Our value proposition is a free radio talk show without the disturbance of ads, no repetitive music, and full of well-researched, well-thought-out content with global thought leaders," said Khandelwal in a press release.

Currently, around 60 percent of listeners are Indian, and the rest of them are abroad. Podcast listening has grown in India in the past years, with monthly listeners (defined as people who listened to at least one podcast last month) totaling four crores in 2018. PwC expects this market to grow beyond 17 crores by 2023.

Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Indian airlines, brokerages affected by global IT outage
Indian airlines, brokerages affected by global IT outage
Jul 19, 2024
By Jayshree P Upadhyay and Jaspreet Kalra MUMBAI, July 19 (Reuters) - Indian airlines and some brokerages faced technical and operational disruptions on Friday amid a global IT outage, multiple traders and airlines said. Several major oil and gas trading desks in London and Singapore were struggling to execute trades due to a cyber outage, six industry sources told Reuters....
QMMM Holdings Prices IPO at $4 Per Share
QMMM Holdings Prices IPO at $4 Per Share
Jul 19, 2024
03:50 AM EDT, 07/19/2024 (MT Newswires) -- QMMM Holdings ( QMMM ) said late Thursday it priced its initial public offering of about 2.2 million ordinary shares at $4 per share for expected gross proceeds of $8.6 million. Underwriters have been granted a 45-day option to purchase up to 322,500 additional shares. The shares are expected to debut on the...
Vision Sensing Acquisition Says Nasdaq Approved Application to Migrate to Capital Market
Vision Sensing Acquisition Says Nasdaq Approved Application to Migrate to Capital Market
Jul 19, 2024
04:09 AM EDT, 07/19/2024 (MT Newswires) -- Vision Sensing Acquisition ( VSAC ) said late Thursday it has successfully migrated to the Nasdaq Capital Market. Earlier this month, the company applied with the Nasdaq Stock Exchange to migrate its listing from the Global Market to the Capital Market, which was approved on July 17. The move is effective as of...
Artiva Biotherapeutics Prices $167 Million IPO
Artiva Biotherapeutics Prices $167 Million IPO
Jul 19, 2024
03:56 AM EDT, 07/19/2024 (MT Newswires) -- Artiva Biotherapeutics (ARTV) said late Thursday it has priced its initial public offering of about 13.9 million common shares at $12 per share for gross proceeds of about $167 million. Underwriters have been granted a 30-day option to purchase up to about 2.1 million additional common shares. The shares are expected to begin...
Copyright 2023-2026 - www.financetom.com All Rights Reserved